Conclusion The integration of molecular modelling and pharmacoepidemological data has the potential to advance drug safety science
Imaging data from 50 patients with DSA-confirmed solitary MDVO who received endovascular treatment and 50 patients without stroke, confirmed by follow-up MRI, was included
therefore, LAT1 ( SLC7A5 ) is essential for maintaining the intracellular SAM concentration
Quality control considerations for the KLOW formulation include verification of individual peptide purity and identity, assessment of copper content and coordination in the GHK-Cu component, evaluation of peptide stability under storage conditions, and confirmation of biological activity for each component
SutherlandL.EbnerT.BurchellB.1993The expression of UDPglucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs.452(January 1993),295301,0006-2952 104